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controls monoubiquitylation-dependent
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1Howard Hughes Medical Institute, University of California, Berkeley, Berkeley,
United States; 2Department of Molecular and Cell Biology, University of California,
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Abstract Metazoan development depends on tightly regulated gene expression programs that
instruct progenitor cells to adopt specialized fates. Recent work found that posttranslational
modifications, such as monoubiquitylation, can determine cell fate also independently of effects on
transcription, yet how monoubiquitylation is implemented during development is poorly
understood. Here, we have identified a regulatory circuit that controls monoubiquitylation-
dependent neural crest specification by the E3 ligase CUL3 and its substrate adaptor KBTBD8. We
found that CUL3KBTBD8 monoubiquitylates its essential targets only after these have been
phosphorylated in multiple motifs by CK2, a kinase whose levels gradually increase during
embryogenesis. Its dependency on multisite phosphorylation allows CUL3KBTBD8 to convert the
slow rise in embryonic CK2 into decisive recognition of ubiquitylation substrates, which in turn is
essential for neural crest specification. We conclude that multisite dependency of an E3 ligase
provides a powerful mechanism for switch-like cell fate transitions controlled by
monoubiquitylation.
DOI: https://doi.org/10.7554/eLife.35407.001
Introduction
Metazoan development relies on accurate cell fate decisions that give rise to the ~200 cell types of
an adult organism. Most differentiation events are switch-like and instruct progenitor cells to deci-
sively adopt a more specialized fate. Epigenetic and transcriptional control have long been known to
drive differentiation, and self-reinforcing circuits built around transcription factors or chromatin
modifiers help establish the switch-like character of these reactions (Atlasi and Stunnenberg, 2017;
Pijnappel et al., 2013). Recent work suggested that posttranslational modifications, including mono-
ubiquitylation, guide differentiation events also independently of gene expression, yet the underly-
ing mechanisms are incompletely understood.
Monoubiquitylation plays a critical role during craniofacial development (Jin et al., 2012;
McGourty et al., 2016; Werner et al., 2015). This process begins with the emergence of neural
crest cells, which originate at the border of the neural plate and non-neural ectoderm and migrate
to various target tissues in a developing organism (Betancur et al., 2010; Simo˜es-Costa and Bron-
ner, 2015). Upon reaching their destination, neural crest cells differentiate into various derivatives,
including chondrocytes, melanocytes, or glial cells. Cranial neural crest cells emerge at the rostral
end of the neural tube, migrate to the branchial arches of the developing head, and differentiate
into chondrocytes that lay out a collagen matrix for subsequent bone formation. Accordingly, the
misregulation of cranial neural crest specification or differentiation results in pathologies that are
characterized by the aberrant formation of craniofacial bone (Achilleos and Trainor, 2015).
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Generation of neural crest cells relies on the E3 ligase CUL3 and its substrate adaptor KBTBD8
(Werner et al., 2015). CUL3KBTBD8 monoubiquitylates the RNA-binding proteins TCOF1 and
NOLC1, which allows these paralogs to associate with each other and recruit enzymes of ribosome
biogenesis and modification. The subsequent production of new and possibly modified ribosomes
reshapes the mRNA translation landscape of stem cells in favor of neural crest specification
(Werner et al., 2015). Underscoring the importance of this regulatory circuit for human biology,
mutations in TCOF1 account for ~90% of cases of the craniofacial disease Treacher Collins Syndrome
(The Treacher Collins Syndrome Colla, 1996; Jones et al., 2008), while additional transcription fac-
tor binding sites in the promoter of KBTBD8 drive melanoma, a cancer of neural crest origin
(Hayward et al., 2017). At later stages of craniofacial development, CUL3 pairs up with a distinct
adaptor, KLHL12, to monoubiquitylate a COPII vesicle coat protein and accelerate collagen secretion
(Jin et al., 2012; McGourty et al., 2016), and mutations in this pathway lead to the craniofacial dis-
order cranio-lenticulo-sutural dysplasia (Boyadjiev et al., 2006). Together, these findings revealed
critical roles of monoubiquitylation in cell differentiation and implied that tight regulation of CUL3 is
essential for human development.
Despite its importance for neural crest specification, mechanisms that ensure accurate
CUL3KBTBD8 activation and function are very poorly understood. While CUL3KBTBD8 is essential for
establishing neural crest cells, it is not required for the maintenance of pluripotent stem cells
(Werner et al., 2015). This suggested that CUL3KBTBD8 engages its targets at specific stages of dif-
ferentiation, yet how it recognizes its substrates at the right time and place is not known. How
monoubiquitylation by CUL3KBTBD8 helps TCOF1 and NOLC1 bind each other is also unclear: while
monoubiquitylation often recruits effector proteins to a modified target (Dikic et al., 2009; Yau and
Rape, 2016), no ubiquitin-binding domains have been identified in TCOF1, NOLC1, or their known
binding partners. Indeed, rather than being organized into structural domains that engage in distinct
interactions, TCOF1 and NOLC1 contain large stretches of acidic residues that are predicted to be
of low structural complexity (Lee et al., 2013). How monoubiquitylation of an intrinsically disordered
protein can precipitate a switch-like transition in cellular state is an open question.
Here, we show that CUL3KBTBD8-dependent monoubiquitylation and neural crest specification
require multisite substrate phosphorylation by CK2, a kinase whose levels gradually increase during
development of the nervous system (Mestres et al., 1994). The essential CUL3KBTBD8-substrates
TCOF1 and NOLC1 contain 10 or more motifs that, following their phosphorylation by CK2, can be
independently recognized by a conserved surface on KBTBD8. We found that multiple CK2 motifs
need to be phosphorylated in the same substrate to mediate both monoubiquitylation by
CUL3KBTBD8 as well as neural crest specification. Multisite dependency allows cells to convert a grad-
ual increase in kinase input, as seen for embryonic CK2, into decisive activation of signaling output
(Gunawardena, 2005; Kapuy et al., 2009). We therefore propose that multisite dependency of
CUL3KBTBD8 provides an elegant mechanism for switch-like cell fate decisions controlled by
monoubiquitylation.
Results
CK2 kinase is required for CUL3KBTBD8-dependent neural crest
specification
CUL3KBTBD8 drives neural crest specification by catalyzing the monoubiquitylation of TCOF1 and
NOLC1 (Werner et al., 2015), but how it selects its targets at the right time during development is
not known. As substrate recognition by cullin-RING ligases often requires posttranslational modifica-
tions or co-adaptor proteins (McGourty et al., 2016; Skaar et al., 2013), we speculated that regula-
tors of CUL3KBTBD8 could be identified as shared interactors of NOLC1 and TCOF1. We therefore
affinity-purified FLAGNOLC1 and FLAGTCOF1 from human 293T embryonic kidney cells, a system that
had previously allowed us to discover stem cell-related signaling pathways (Jin et al., 2012;
McGourty et al., 2016; Werner et al., 2015), and analyzed the immunoprecipitates by CompPASS
mass spectrometry (Huttlin et al., 2015; Sowa et al., 2009). These experiments showed that both
NOLC1 and TCOF1 interacted with all subunits of the CK2 kinase (Figure 1A), which was consistent
with earlier studies that found these proteins to be phosphorylated by CK2 (Jones et al., 1999;
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Figure 1. CK2 kinase is required for CUL3KBTBD8-substrate binding and ubiquitylation in cells. (A) Both NOLC1 and TCOF1 associate with the CK2
kinase. FLAGNOLC1 and FLAGTCOF1 were affinity-purified from 293 T cells and specific binding partners were determined by CompPASS mass
spectrometry. Total spectral counts (TSCs) of specific interactors were normalized to 1000 TSCs for each bait protein and plotted against each other.
For each CUL3KBTBD8-substrate, three independent affinity-purification and mass spectrometry experiments were performed. The results of each affinity
experiments were compared to a database, which included ~100 unrelated affinity-purifications performed with the same antibody and in the same cell
line. (B) TCOF1 and NOLC1 associate with endogenous CK2 in cells. FLAGNOLC1 and FLAGTCOF1 were affinity-purified from 293 T cells, and co-
purifying proteins were identified by western blotting using the indicated antibodies. KLHL12FLAG was used as a negative control. The low molecular
weight species seen in TCOF1 samples are proteolytic degradation products caused by partial cleavage of the large and intrinsically disordered TCOF1
during the affinity-purification. (C) CK2 is required for substrate recognition by CUL3KBTBD8 in cells. 293 T cells were depleted of CK2b using shRNAs
Figure 1 continued on next page
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Meier and Blobel, 1992; Wise et al., 1997). We confirmed the robust interaction of NOLC1 and
TCOF1 with CK2a and CK2b by affinity-purification and western blotting (Figure 1B).
Expression of CK2 gradually increases during embryogenesis at times of neural crest develop-
ment (Mestres et al., 1994), and CK2 activity had been detected in the branchial arches that are
important for craniofacial bone development (Jones et al., 1999). Together with our binding stud-
ies, these observations suggested that phosphorylation by CK2 might play a role in target recogni-
tion and monoubiquitylation by CUL3KBTBD8. To test this hypothesis, we purified KBTBD8, the
subunit of CUL3KBTBD8 that directly binds substrates, from cells that were transfected with shRNAs
against CK2b, that is the subunit shared by both CK2a/b and CK2a’/b complexes, and treated with a
small molecule CK2 inhibitor (CX4945). Such effective inhibition of CK2 prevented NOLC1 or TCOF1
from binding to CUL3KBTBD8, whereas PKN1, a protein that associates with a different surface of
KBTBD8 and is not important for neural crest specification (Werner et al., 2015), was still recog-
nized (Figure 1C). Inhibition of CK2 also blocked CUL3KBTBD8-dependent monoubiquitylation of
TCOF1 and NOLC1, while the modification of an unrelated protein, PCNA, was not impaired
(Figure 1D,E). In line with these results, inactivation of PP1 and PP2A phosphatases, which oppose
CK2 in cells (Popescu et al., 2009), strongly promoted substrate binding and monoubiquitylation by
CUL3KBTBD8 (Figure 1F,G). Interestingly, the phosphatase subunit PP1A decreases during neural
crest specification in vitro at times when TCOF1 and NOLC1 engage CUL3KBTBD8 (Figure 1—figure
supplement 1A,B).
Monoubiquitylation by CUL3KBTBD8 allows NOLC1 and TCOF1 to bind each other and recruit
enzymes required for ribosome biogenesis and neural crest specification (Werner et al., 2015). To
determine whether CK2 is required for CUL3KBTBD8-dependent signaling, we therefore asked
whether CK2 inhibition impaired formation of TCOF1-NOLC1 complexes. As seen before
(Werner et al., 2015), we found that the expression of KBTBD8 caused TCOF1 and NOLC1 to asso-
ciate with each other (Figure 2A). Loss of CK2 prevented the CUL3KBTBD8-dependent assembly of
the TCOF1-NOLC1 platform to the same extent as inactivation of KBTBD8 through mutation of its
CUL3-binding motif (KBTBD8Y74A) (Figure 2A). Accordingly, depletion of CK2b or small molecule
inhibition of CK2 kinase activity interfered with neural crest specification (Figure 2B–D). We had pre-
viously shown that hESCs that fail to produce neural crest cells induce a compensatory pathway char-
acterized by increased expression of forebrain markers, FOXG1 and SIX3 (Werner et al., 2015), and
we observed the same response if hESCs were subjected to differentiation in the absence of CK2
(Figure 2C). By contrast, low concentrations of the PP1 and PP2A inhibitor okadaic acid increased
the efficiency of neural crest specification (Figure 2—figure supplement 1). We conclude that CK2
is required for the recognition and monoubiquitylation of TCOF1 and NOLC1 by CUL3KBTBD8, forma-
tion of a TCOF1-NOLC1 ribosome biogenesis platform, and neural crest specification.
Figure 1 continued
and the activity of the remaining CK2 kinase was simultaneously inhibited using the small molecule CX4945. KBTBD8FLAG, the substrate adaptor of
CUL3, was affinity-purified and bound endogenous proteins were detected by western blotting using the indicated antibodies. PKN1 is a specific
binding partner of KBTBD8 that is not known to be ubiquitylated by CUL3KBTBD8 and that is not important for neural crest specification. (D) CK2 is
required for monoubiquitylation of TCOF1 in cells. Ubiquitylated proteins were purified under denaturing conditions from 293 T cells expressing
HISubiquitin. Ubiquitylated proteins were detected by western blotting using the indicated antibodies. PCNA is ubiquitylated by a distinct E3 ligase and
hence is used as a control for general ubiquitylation efficiency; unmodified PCNA is not detected in NiNTA pulldowns, demonstrating the specificity of
this assay. Input: 3% of lysate used for denaturing purification. (E) CK2 is required for monoubiquitylation of NOLC1 in cells. Ubiquitylated NOLC1 was
purified both in the absence or presence of CK2 inhibitors, as described for TCOF1 above. Input: 3% of lysate used for denaturing purification. (F)
Inhibition of PP1 and PP2A phosphatases, which counteract CK2 in cells, promotes substrate binding by CUL3KBTBD8. KBTBD8FLAG or the negative
control KLHL12FLAG were affinity-purified from cells treated with the PP1/PP2A-inhibitor okadaic acid. Co-purifying proteins, including endogenous
TCOF1, NOLC1, and the control KBTBD8-interactor PKN1, were detected by western blotting. This experiment was performed at smaller scale than
Figure 1C, explaining the lack of TCOF1 binding to KBTBD8 under conditions without phosphatase inhibitors. (G) Inhibition of PP1/PP2A phosphatases
increases TCOF1 ubiquitylation in cells. Ubiquitylated HATCOF1 was purified under denaturing conditions from 293 T cells expressing HISubiquitin and
treated with or without okadaic acid. Ubiquitylated proteins were detected by Western blotting. Input: 3% of lysate used for denaturing purification.
DOI: https://doi.org/10.7554/eLife.35407.002
The following figure supplement is available for figure 1:
Figure supplement 1. Expression analysis of CK2 and PP1/PP2A in differentiating hESCs.
DOI: https://doi.org/10.7554/eLife.35407.003
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Figure 2. CK2 is required for neural crest specification. (A) CK2 is required for CUL3KBTBD8- and ubiquitylation-dependent formation of TCOF1-NOLC1
complexes. FLAGTCOF1 was affinity-purified from control- or CK2 activity-depleted cells (shCK2b/CX4945) that expressed WT-KBTBD8 or mutant
KBTBD8Y74A, which is unable to bind CUL3 and thus cannot catalyze monoubiquitylation. Bound proteins, including endogenous NOLC1, were
detected by western blotting. KLHL12FLAG was used as a control protein. (B) CK2 activity is required for neural crest formation from hESCs. H1 hESCs
were subjected to neural conversion in the absence or presence of 1 mM CK2 inhibitor CX4945. Expression of markers for central nervous system
precursor (PAX6) or the neural crest (SOX10) was analyzed by Western blotting. Differentiation was monitored by following the stem cell-specific
transcription factor NANOG, using specific antibodies. (C) CK2 controls a switch between CNS and neural crest precursors. Neural conversion of H1
hESCs was induced under control conditions (shControl), in the presence of an shRNA to deplete endogenous CK2b (shCK2b), or in the presence of 1
mM CK2 inhibitor CX4945 (shControl/CX4549). Differentiation was followed by qRT-PCR analysis of markers of the CNS (SOX2, PAX6, FOXG1, SIX3) or
the neural crest (SNAIL2, SOX10, FOXD3, EDNRA, TFAP2). Fold change expression is relative to shControl at day 6 of differentiation. Error bars denote
s.e.m. of three technical replicates. (D) CK2 is required for neural crest specification, as detected at the single cell level. H1 hESCs were subjected to
neural conversion in the absence of presence of indicated concentrations of CK2 inhibitor CX4945 for 7d. Formation of neural crest cells was assessed
by indirect immunofluorescence microscopy using antibodies specific to SOX10. Representative images are shown. SOX10 positive cells were
quantified from three independent experiments and expressed as percentage of total cells imaged. Error bars denote standard deviation.
DOI: https://doi.org/10.7554/eLife.35407.004
Figure 2 continued on next page
Werner et al. eLife 2018;7:e35407. DOI: https://doi.org/10.7554/eLife.35407 5 of 27
Research article Biochemistry and Chemical Biology Cell Biology
A conserved loop in KBTBD8 is required for CK2 substrate recognition
By phosphorylating residues embedded in acidic sequences, CK2 generates highly negatively
charged proteins (Bian et al., 2013; Meggio and Pinna, 2003). As CK2 appeared to drive target
recognition by CUL3KBTBD8, we expected that a complementary positively charged motif in KBTBD8
might mediate substrate binding. By investigating sequence conservation among 54 vertebrate
KBTBD8 homologs, we found a highly conserved positively charged loop that was in proximity of
Trp579 (Figure 3A; Figure 3—figure supplement 1), a residue that is known to be required for sub-
strate binding by CUL3KBTBD8 (Werner et al., 2015). Replacing five His and Lys residues within this
loop with Ala (KBTBD85HK) prevented binding of KBTBD8 to NOLC1 and TCOF1, whereas the inter-
action of KBTBD8 with CUL3 or PKN1 was not affected by this charge removal (Figure 3B). Similar
observations were made by affinity-purification coupled to mass spectrometry, where mutation of its
positively charged loop blocked KBTBD8-binding to TCOF1 or NOLC1 (Figure 3C).
In line with these results, KBTBD85HK was an inactive substrate adaptor that was unable to pro-
mote NOLC1 or TCOF1 ubiquitylation in cells (Figure 3D,E) and failed to induce formation of the
NOLC1-TCOF1 complex (Figure 3F). Moreover, if KBTBD85HK was the only KBTBD8 variant
expressed in hESCs, cells did not differentiate into neural crest cells and instead showed the com-
pensatory induction of the forebrain markers FOXG1 and SIX3 upon neural conversion (Figure 3G,
H). Thus, a positively charged loop in KBTBD8 is required for CUL3KBTBD8 substrate monoubiquityla-
tion and neural crest specification. This strongly suggested that CK2 phosphorylates CUL3KBTBD8-
substrates to mark them for monoubiquitylation.
CK2 is required for NOLC1 and TCOF1 recognition by CUL3KBTBD8
To test the above hypothesis, we purified TCOF1 and NOLC1 fragments that contained two CK2
consensus motifs with several phosphorylation sites each. As evidenced by a CK2- and ATP-depen-
dent increase in molecular weight, these proteins were efficiently phosphorylated by the CK2a/b
holoenzyme in vitro (Figure 4A). Importantly, when we then incubated purified KBTBD8 with either
unmodified or phosphorylated TCOF1 or NOLC1, we found that KBTBD8 selectively bound the
phosphorylated, but not unmodified, targets (Figure 4B,C). KBTBD8 did not recognize phosphory-
lated substrates if its Trp579 or the positively charged 5HK-patch were mutated (Figure 4B,C), and
KBTBD8 also did not bind a TCOF1 fragment, whose CK2 motif was destroyed by introduction of
positively charged Arg residues or mutation of seven phosphoacceptor Ser residues (Figure 4D). By
contrast, Phe550 of KBTBD8, which is required for recognition of PKN1 (Werner et al., 2015), was
not needed for the interaction between phosphorylated TCOF1 or NOLC1 and KBTBD8 (Figure 4B,
C).
Titration experiments relying on fluorescence polarization revealed that KBTBD8 bound a single
phosphorylated CK2 motif with a KD of ~1.4 mM, while we did not detect any interaction with an
unphosphorylated TCOF1 peptide (Figure 4E). A monomeric variant of KBTBD8, in which residues
at the BTB interface were mutated to prevent adaptor dimerization (Zhuang et al., 2009), bound
the phosphorylated CK2 motif with a similar affinity as the wildtype dimeric KBTBD8 (Figure 4E),
whereas mutation of its positively charged surface (KBTBD85HK) or competition with a negatively
charged molecule known to interfere with CK2 substrate recognition, IP6, prevented substrate bind-
ing by KBTBD8 (Figure 4F,G). The latter finding underscores the importance of electrostatic interac-
tions for substrate recognition by CUL3KBTBD8.
Having observed the direct binding of phosphorylated TCOF1 to KBTBD8, we were able to
reconstitute CUL3KBTBD8-dependent substrate monoubiquitylation in a purified setting. We first
allowed KBTBD8 to bind a phosphorylated TCOF1 fragment with two CK2-motifs, a step that was
required for specific substrate modification. We then added neddylated CUL3-RBX1, E1, E2, and
ubiquitin and found that the phosphorylated TCOF1 was efficiently monoubiquitylated (Figure 4H).
No ubiquitin transfer was detected in the absence of ATP or KBTBD8 (Figure 4H); moreover, we
Figure 2 continued
The following figure supplement is available for figure 2:
Figure supplement 1. Phosphatase inhibition increases the efficiency of neural crest specification.
DOI: https://doi.org/10.7554/eLife.35407.005
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Figure 3. A conserved loop in KBTBD8 is required for CK2-substrate recognition. (A) KBTBD8 contains a loop with five His- or Lys-residues that is close
to W579, a KBTBD8-residue known to be important for substrate recognition. Depicted is a structural model of the Kelch-domain of KBTBD8; W579 is
shown in red, whereas the 5HK-loop is shown in blue. (B) The 5HK-loop in KBTBD8 is required for substrate recognition. KBTBD8FLAG or KBTBD85HK-
FLAG (i.e. a KBTBD8-mutant in which all five His- or Lys-residues in the conserved loop were exchanged to Ala) were affinity-purified from cells. Co-
purifying TCOF1, NOLC1, or PKN1 were detected by western blotting. (C) The 5HK-loop of KBTBD8 is essential for substrate recognition. The indicated
KBTBD8 variants (wt; W579A; 5HK-Ala; F550A; Y74A) were affinity-purified from 293 T cells and analyzed for binding partners by CompPASS mass
spectrometry. The heatmap depicts the relative binding of interactors identified for wild-type KBTBD8 in the respective KBTBD8 variant (black = no
interaction, red = equal or more interaction). A quantification of normalized total spectral counts (TSCs) of three biological replicates is shown for the
wild-type KBTBD8 affinity-purification is shown on the left. (D) The 5HK-loop of KBTBD8 is required for TCOF1 ubiquitylation in cells. Ubiquitylated
proteins were purified under denaturing conditions from 293 T cells expressing HISubiquitin. Modified proteins were detected by western blotting,
using the indicated antibodies. (E) The 5HK-loop of KBTBD8 is required for NOLC1 ubiquitylation in cells. Ubiquitylated proteins were purified from 293
Figure 3 continued on next page
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observed a strong inhibition of ubiquitylation in the presence of KBTBD8 variants that were less effi-
cient in binding TCOF1, including KBTBD85HK or KBTBD8W579A (Figure 4I). We conclude that phos-
phorylation by CK2 marks TCOF1 and NOLC1 for recognition and monoubiquitylation by
CUL3KBTBD8.
TCOF1 and NOLC1 contain multiple recognition motifs for CUL3KBTBD8
Interestingly, while KBTBD8W579A did not bind TCOF1 fragments with two or more CK2 motifs
(Figure 4B), it associated with a peptide containing a single phosphorylated CK2 motif (Figure 4F).
This implied that Trp579 stabilizes a conformation of KBTBD8 that is required for this E3 to engage
more than one negatively charged CK2 motif at the same time. Consistent with this, we noticed that
TCOF1 and NOLC1 each have more than 10 CK2 motifs that are embedded in the central acidic
domain of low structural complexity (Figure 5A). To assess whether these motifs provide
CUL3KBTBD8 recognition elements, we purified 24 distinct CK2 repeats from TCOF1 and NOLC1 and
tested whether they could bind KBTBD8 in vitro. We found that KBTBD8 associated in a CK2-depen-
dent manner with 10 CK2 motifs in TCOF1 and nine counterparts in NOLC1 (Figure 5B). These
results were supported by cellular studies: TCOF1 was monoubiquitylated on distinct Lys residues
that were in close proximity to nine different phosphorylated CK2 motifs (Figure 5C) (Bian et al.,
2013). TCOF1 and NOLC1 therefore do not contain a single, but many recognition motifs for
CUL3KBTBD8.
Multisite dependency of CUL3KBTBD8 substrate recognition
Why do TCOF1 and NOLC1 have so many recognition motifs for their E3? Multiple E3 binding sites
might ensure robust substrate ubiquitylation, as backup sites could buffer mutation or defective
phosphorylation of a single motif. If this were to be the case, increasing the number of CK2 motifs
should not improve substrate affinity under conditions of saturating kinase activity. Alternatively,
studies on the cyclin-dependent kinase inhibitor SIC1 found that multiple E3-binding sites could pro-
duce allovancy (Csizmok et al., 2017; Nash et al., 2001; Tang et al., 2007): following dissociation
of one SIC1-degron, neighboring E3 recognition motifs already in proximity to the enzyme rapidly
rebind and thereby retain the interaction between the substrate and its E3. It would also be possible
that multiple CK2 motifs access different positively charged patches on KBTBD8 in a multivalent
manner. If the latter two mechanisms were at play for CUL3KBTBD8, adding more CK2 sites would be
expected to increase the affinity of substrates for this E3. Supporting these models, we found in a
competition assay that the more CK2 sites were included in TCOF1, the better it bound KBTBD8
(Figure 5D,E; Figure 5—figure supplement 1). We noted a particularly prominent increase in sub-
strate affinity if TCOF1 fragments contained six or more CK2 sites (Figure 5D,E).
We confirmed these results by monitoring the ability of immobilized KBTBD8 to retain TCOF1
fragments with increasing numbers of CK2 motifs. When assayed at high substrate concentration,
TCOF1 fragments with 2, 3, 4, 6, and 8 CK2 motifs were all able to bind KBTBD8 in a CK2-depen-
dent manner (Figure 5F). However, if all peptides were incubated with KBTBD8 at the same time,
Figure 3 continued
T cells under denaturing conditions and analyzed as described above. (F) The 5HK loop of KBTBD8 is required for TCOF1-NOLC1 complex formation.
Cells expressing HATCOF1 and either KBTBD8FLAG, KBTBD85HK-FLAG, or the control protein KLHL12FLAG were subjected to anti-HA affinity-purification
and analyzed for co-purifying proteins by western blotting. ARBB1 and ARBB2 binding to TCOF1 shows that the efficiency of affinity-purification was
identical under all conditions. (G) The 5HK loop in KBTBD8 is required for neural crest specification. H1 hESCs were depleted of endogenous KBTBD8
using stably expressed shRNAs. Where indicated, hESCs were reconstituted with shRNA-resistant wild-type (WT) or mutant (5HK) KBTBD8.
Differentiation was followed be western blotting using markers of the neural crest (SOX10), CNS precursors (PAX6), or pluripotency (NANOG; OCT4).
(H) The 5HK loop of KBTBD8 is required for neural crest specification. H1 hESCs were depleted of KBTBD8 and reconstituted with shRNA-resistant
wild-type KBTBD8 or mutant KBTBD85HK. Expression of markers of CNS/forebrain (FOXG1, SIX3, PAX6) or the neural crest (SOX10, EDNRA, FOXD3,
TFAP2, SNAIL2) was followed by qRT-PCR. Fold change expression is relative to shControl at day 6 of differentiation. Error bars denote s.e.m. of three
technical replicates.
DOI: https://doi.org/10.7554/eLife.35407.006
The following figure supplement is available for figure 3:
Figure supplement 1. Conservation analysis of KBTBD8.
DOI: https://doi.org/10.7554/eLife.35407.007
Werner et al. eLife 2018;7:e35407. DOI: https://doi.org/10.7554/eLife.35407 8 of 27
Research article Biochemistry and Chemical Biology Cell Biology
Figure 4. CK2 marks CUL3KBTBD8-substrates for monoubiquitylation in vitro. (A) TCOF1 and NOLC1 are phosphorylated by recombinant CK2 in vitro.
Recombinant Flag-tagged TCOF1190-364 or NOLC176-187 fragments with two CK2 motifs (Flag-TCOF1*, Flag-NOLC1*) were incubated with either the
catalytic subunit CK2a or complexes between CK2a and the regulatory subunit CK2b. ATP was added as indicated, and proteins were detected by
Coomassie staining. The molecular weight shift observed in the presence of both CK2 and ATP is indicative of phosphorylation. The red asterisk marks
Figure 4 continued on next page
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only TCOF1 fragments with six or more CK2 motifs were retained by the E3 (Figure 5F). When
tested at substrate concentrations below the KD of a single CK2 motif, KBTBD8 only bound frag-
ments with multiple CK2 motifs even in the absence of competition (Figure 5G). Under these condi-
tions, KBTBD8 required dimerization for target recognition (Figure 5G), which was also seen with
KBTBD8 immunoprecipitated from cells (Figure 5H), as well as in in vitro ubiquitylation assays
(Figure 4I). In contrast to the effects on affinity, increasing the number of E3-binding sites did not
alter the nature of ubiquitylation, and a TCOF1-fragment with eight CK2 motifs was still only monou-
biquitylated by CUL3KBTBD8 (Figure 5I). Thus, CUL3KBTBD8 requires multiple CK2 motifs for optimal
substrate recognition, a feature that is referred to as multisite dependency.
Multisite dependency allows cells to translate small increases in the levels or activity of a kinase
into large changes in signaling output (Csizmok et al., 2016; Gunawardena, 2005), which can intro-
duce ultrasensitivity needed for switch-like differentiation (Serber and Ferrell, 2007). To test
whether its mode of substrate recognition enables CUL3KBTBD8 to convert the gradual increase in
CK2 levels during embryogenesis into decisive recognition of NOLC1 or TCOF1, we titrated CK2a/b
into reactions that monitored the binding of a TCOF1 fragment with eight CK2 motifs to KBTBD8;
to mimic the cellular situation, where many proteins compete for access to CK2 (Bian et al., 2013),
we also included an excess competitor with two CK2 motifs. Notably, we found that in the presence
of the competitor, TCOF1 was only able to bind KBTBD8 at high CK2 levels, where the affinity gain
provided by eight phosphorylated CK2 motifs overcame the concentration advantage of the com-
petitor (Figure 5J). Accordingly, the Hill coefficient of the TCOF1-KBTBD8 binding reaction
increased from ~1 in the absence of a competitor to ~3.5 in its presence, which is indicative of ultra-
sensitive behavior. Based on these observations, we infer that multisite dependency of CUL3KBTBD8
provides a mechanism for cells to translate a slow increase in CK2 levels into switch-like E3 substrate
recognition.
Multisite dependency by CUL3KBTBD8 controls substrate recognition in
cells
We finally wished to determine whether multisite dependency governed substrate regulation by
CUL3KBTBD8 in cells. Different from in vitro conditions, we could not address this question by
expressing TCOF1 or NOLC1 fragments with an increasing number of CK2 motifs, as truncated poly-
peptides would miss interaction surfaces for proteins involved in ribosome biogenesis and neural
crest specification (Lin and Yeh, 2009; Prieto and McStay, 2007). Instead, we decided to inactivate
distinct CK2 motifs in full-length NOLC1, which could be introduced into cells more reproducibly
Figure 4 continued
CK2b, as detected at its highest concentration. In the absence of the stabilizing CK2b-subunit, high concentrations of CK2a likely lead to aggregation
and reduced TCOF1 phosphorylation. (B) KBTBD8 selectively binds phosphorylated TCOF1. The binding of recombinant Flag-TCOF1* (containing two
CK2 motifs) to KBTBD8 was analyzed in the absence or presence of CK2a/b. TCOF1 was immobilized on beads and bound KBTBD8 was detected by
Coomassie staining. The KBTBD8 variants tested (WT, 5HK, W579A, F550A) are indicated on the right. (C) KBTBD8 selectively binds phosphorylated
NOLC1. The binding of recombinant Flag-NOLC1* (containing two CK2 motifs) to KBTBD8 was analyzed as described above for TCOF1. (D) Mutation
of a CK2 motif obliterates its recognition by KBTBD8. The indicated CK2 motif of TCOF1197-213 was altered by introduction of one or two Arg residues
(sites indicated by red arrows in scheme above) or by mutation of one (S1A), three (S3A) or all seven (S7A) phosphoacceptor Ser residues. Binding to
immobilized KBTBD8 was analyzed either in the absence or presence of CK2, using Coomassie staining. (E) KBTBD8 binds a CK2 motif in TCOF1 in a
phosphorylation-dependent manner. A single N-terminally TAMRA-labeled CK2 motif of TCOF1194-216 was either incubated with CK2 (‘-PO4’) or kept
unmodified and incubated with increasing concentrations of recombinant KBTBD8. Binding of KBTBD8 to the CK2 motif was measured as change in
fluorescence polarization, and the dissociation constant of the binding reaction was determined by fitting to a two-state binding curve. In addition to
wild-type KBTBD8, the ability of a monomeric variant of KBTBD8 (KBTBD8-Ddim) was monitored (green curves). In the absence of CK2, no measurable
binding was detected (red curves). (F) Mutation of the 5HK loop, but not of W579, obliterates binding of KBTBD8 to a single CK2 motif. Binding of
distinct KBTBD8 variants (WT, Ddim, W579A, 5HK) to a phosphorylated CK2 motif of TCOF1 was measured by fluorescence polarization. (G) Substrate
binding by KBTBD8 is likely electrostatic in nature. Binding of a single phosphorylated CK2 motif from TCOF1 to recombinant KBTBD8 was measured
by fluorescence polarization in the presence of increasing concentrations of the highly negatively charged molecule inositolehexakisphosphate (IP6). (H)
TCOF1 is monoubiquitylated in vitro. A TCOF1 fragment containing two CK2 motifs (‘R1/2’) was first phosphorylated by CK2a/b and then immobilized
on FLAG-agarose followed by incubation with KBTBD8; immobilization interfered with non-specific ubiquitylation of the substrate peptide. Next,
recombinant neddylated CUL3/Rbx1, E1, UBE2D3, ubiquitin, and ATP were added as indicated, and ubiquitylation of TCOF1 was followed by Western
blotting. (I) Monoubiquitylation of TCOF1-R1/2 by CUL3KBTBD8 was analyzed as described above, using the indicated KBTBD8 mutants.
DOI: https://doi.org/10.7554/eLife.35407.008
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Figure 5. Multisite dependency of substrate recognition by CUL3KBTBD8 in vitro. (A) TCOF1 and NOLC1 contain multiple CK2 motifs (light green).
Functional motifs are marked with a red dot (non-functional motifs typically contain Arg substitutions that are incompatible with recognition by CK2).
The LisH domain is a protein interaction module found in many proteins, but often with unknown function. (B) Multiple CK2 motifs are recognized by
KBTBD8. TCOF1 or NOLC1 fragments containing single CK2 motifs (number according to position in sequence) were incubated with buffer or with
CK2/ATP, immobilized on beads, and incubated with recombinant KBTBD8. Bound KBTBD8 was visualized by western blotting using a specific
antibody. (C) TCOF1 is ubiquitylated in vivo on multiple Lys residues that are all in close proximity to CK2 motifs. Ubiquitylated TCOF1 was purified
under denaturing conditions from 293 T cells and ubiquitylated Lys residues were determined by mass spectrometry. The figure depicts the location of
ubiquitylated lysine residues identified in individual peptides. (D) The more CK2 motifs are in a substrate, the better it binds to KBTBD8. A single
phosphorylated and fluorescently labeled CK2 motif of TCOF1 was bound to KBTBD8. Unlabeled TCOF1 competitor fragments containing either two
(R1/2), three (R1/3), four (R1/4), six (R1/6) or eight (R1/8) CK2 motifs were phosphorylated and titrated into the binding reaction, and dissociation of the
Figure 5 continued on next page
Werner et al. eLife 2018;7:e35407. DOI: https://doi.org/10.7554/eLife.35407 11 of 27
Research article Biochemistry and Chemical Biology Cell Biology
than the much larger TCOF1. We then tested how many functional CK2 motifs were required for
NOLC1 recognition by CUL3KBTBD8.
Building off of our observation that introduction of Arg residues destroyed CK2 motifs
(Figure 4D), we first generated a NOLC1 variant in which all but one CK2 consensus sites were inac-
tivated (NOLC1CK1). Contrary to the wildtype protein, NOLC1CK1 failed to bind endogenous
KBTBD8 either in 293 T cells or in differentiating hESCs (Figure 6A,B). Thus, although a single CK2
motif can mediate binding of NOLC1 to KBTBD8 in vitro (Figure 5B), it is not sufficient to mediate
its CUL3KBTBD8-recognition in vivo. We then reintroduced CK2 motifs into NOLC1CK1 to generate
NOLC1CK3 (i.e. NOLC1 with three intact CK2 consensus sites), NOLC1CK5, NOLC1CK7, and
NOLC1CK9 (Figure 6C). Upon analyzing the behavior of these variants toward endogenous or over-
expressed KBTBD8, we found that multiple CK2 repeats were required for an interaction between
NOLC1 and KBTBD8, and wild-type NOLC1 with 10 CK2 motifs showed the strongest binding to
KBTBD8 (Figure 6C,E). In line with these results, we found that CUL3KBTBD8-dependent monoubiqui-
tylation of NOLC1 and its ubiquitin-dependent association with TCOF1 required multiple CK2
motifs, and the most robust signaling was again observed in the presence of all phosphorylation
sites (Figure 6D,E). Interestingly, NOLC1 variants with five or less CK2 motifs were ubiquitylated by
an E3 ligase distinct from KBTBD8 (Figure 6D), which did not promote TCOF1-NOLC1 complex for-
mation and has an unknown function (Figure 6E).
To determine how many CK2 motifs were required for NOLC1-dependent neural crest specifica-
tion, we depleted NOLC1 from hESCs using stably expressed shRNAs that targeted the 3’-UTR of
its mRNA. Consistent with previous findings (Werner et al., 2015), the loss of NOLC1 prevented
neural crest specification and induced compensatory expression of forebrain markers, as seen by
qRT-PCR, western blotting, or fluorescence microscopy (Figure 7A–D). These phenotypes could be
rescued by shRNA-resistant wild-type NOLC1, which underscores the specificity of our depletion
approach (Figure 7A–D). When we introduced NOLC1 variants with increasing numbers of CK2
sites, we found that only those containing seven or more CK2 motifs were able to support neural
crest specification (Figure 7A–D). As seen with KBTBD8 binding and formation of the NOLC1-
TCOF1 platform, wild-type NOLC1 containing all ten CK2 sites was most efficient in driving neural
crest specification. Although it is difficult to exclude unknown effects of point mutations, the ability
of NOLC1 variants to support neural crest specification therefore closely mirrored their ubiquityla-
tion by CUL3KBTBD8 in cells, and seven or more CK2 motifs need to be present in NOLC1 to allow
for modification and function of this ribosome biogenesis factor. We conclude that multisite-
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reporter peptide was monitored by loss of fluorescence polarization. (E) The increase in affinity afforded by multiple CK2 motifs also applies to
monomeric KBTBD8. A monomeric variant of KBTBD8 was produced by mutation of conserved residues at the BTB dimer interface, as described for
KLHL12 (McGourty et al., 2016). Binding of a single phosphorylated CK2 motif of TCOF1 to monomeric KBTBD8 was then monitored in the presence
of competitor peptides by fluorescence polarization, as described above. (F) Multiple CK2 motifs increase substrate affinity for KBTBD8. TCOF1
fragments containing either two (R1/2), three (R1/3), four (R1/4), six (R1/6) or eight (R1/8) CK2 motifs were incubated with immobilized KBTBD8 either in
the presence or absence of CK2. In the last two lanes, all TCOF1 fragments were mixed and incubated at the same time with KBTBD8. Binding was
monitored by western botting (top lanes: input; bottom lanes: KBTBD8-immunoprecipitation). (G) Multiple CK2 motifs increase substrate affinity
towards KBTBD8 at low substrate concentrations. Upper panel: 450 nM of TCOF1 fragments with a single (F2) or multiple (R1/2, R1/4, R1/8) CK2 motifs
were incubated with either wild-type KBTBD8 or monomeric KBTBD8Ddim, and KBTBD8 was then affinity-purified using a specific antibody. Lower panel:
Same binding reaction as above, but TCOF1 was immobilized on beads. Complex formation was analyzed by western blotting. (H) Dimerization of
KBTBD8 is required for TCOF1, but not PKN1, binding in cells. Cells expressing indicated KBTBD8 variants were subjected to KBTBD8FLAG affinity-
purification and analyzed for dimerization (KBTBD8HA), CUL3-binding, or substrate recognition (TCOF1, PKN1) using Western blotting with specific
antibodies. (I) CUL3KBTBD8-substrates with multiple CK2 motifs are monoubiquitylated. Ubiquitylation of TCOF1-R1/8, a fragment containing eight CK2
motifs, was analyzed in vitro using purified neddylated CUL3-RBX1, KBTBD8, E1, UBE2D3, ubiquitin and ATP, as described above. (J) Ultrasensitivity of
the KBTBD8-TCOF1 interaction. Binding of TCOF1-R1/8 to KBTBD8 was analyzed in the presence of increasing CK2 concentrations, as described in the
Figure 5F. Western blots of three independent experiments were quantified by Image J, and error bars denote standard deviation. Green curve:
binding reaction in the absence of competitor; blue curve: binding of TCOF1-R1/8 in the presence of a ten-fold excess of TCOF1-R1/2, which mimics
endogenous CK2 substrates that typically have one or two CK2 motifs.
DOI: https://doi.org/10.7554/eLife.35407.009
The following figure supplement is available for figure 5:
Figure supplement 1. N- and C-terminal TCOF1 fragments both require multiple CK2 motifs for recognition.
DOI: https://doi.org/10.7554/eLife.35407.010
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Figure 6. Multisite dependency of CUL3KBTBD8 substrate recognition in cells. (A) A single CK2 motif is not sufficient for substrate recognition by
KBTBD8 in cells. Wild-type FLAGNOLC1 or a mutant containing only a single CK2 motif (FLAGNOLC1CK1) were affinity-purified from 293 T cells and
analyzed for binding to endogenous KBTBD8 and CK2 by western blotting using specific antibodies. (B) A single CK2 motif is not sufficient for KBTBD8
and TCOF1 recognition by NOLC1 in differentiating hESCs. FLAGNOLC1 was affinity-purified from hESCs or hESCs subjected to 1 day of neural
Figure 6 continued on next page
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dependency of CUL3KBTBD8 governs monoubiquitylation-dependent neural crest specification, a
switch-like change in cell fate.
Discussion
The central role of CUL3 in metazoan development (McGourty et al., 2016; Singer et al., 1999;
Werner et al., 2015), and its frequent misregulation in cancer, autism, or hypertension
(Hayward et al., 2017; Northcott et al., 2017; Rape, 2018), implies that this E3 ligase needs to be
under strict control. Providing a first mechanism of regulation, CUL3KEAP1 constitutively ubiquitylates
the transcription factor NRF2, until this reaction is prevented upon cysteine modification of KEAP1
during oxidative stress (Furukawa and Xiong, 2005; Tong et al., 2006). Conversely, CUL3KLHL12
regulates COPII vesicle size only after calcium has been released from the endoplasmic reticulum
(McGourty et al., 2016). Here, we add another layer of regulation by showing that multisite phos-
phorylation is required for target recognition by CUL3KBTBD8, an E3 ligase that controls neural crest
specification (Werner et al., 2015). While phosphorylation is a common event in promoting sub-
strate recognition by SCF E3 ligases (Skaar et al., 2013), this example shows that similar regulation
exists for the CUL3 family of E3 ligases.
Multisite dependency of substrate recognition by CUL3KBTBD8
The essential CUL3KBTBD8-substrates TCOF1 and NOLC1 each contain 10 or more motifs that can be
independently phosphorylated by CK2 and mediate binding to KBTBD8 with comparable efficiency
in vitro. Proteomic approaches found most of these CK2 motifs to be phosphorylated in cells
(Bian et al., 2013), which we confirmed in our own experiments. The CK2 motifs are spread through-
out the central disordered domains of TCOF1 and NOLC1, and accordingly, we detected nine dis-
tinct monoubiquitylation sites on TCOF1 that were always in proximity to CK2 motifs. While we
might have missed cellular ubiquitylation sites, these observations already suggested that multiple
CK2 sites can function as CUL3KBTBD8-recognition motifs.
Fluorescence polarization measurements showed that KBTBD8 recognizes a single CK2 motif with
a dissociation constant of ~1 mM, and steady-state assays indicated that the affinity of KBTBD8 for
most CK2 motifs in TCOF1 or NOLC1 is in a similar range. KBTBD8 therefore binds more than 10
distinct motifs in TCOF1 or NOLC1 with an affinity that is akin to that of the E3 ligases SCFCDC4 or
UBR1 to their targets (Csizmok et al., 2017; Tasaki et al., 2009). However, a single CK2 motif was
not sufficient for substrate binding by CUL3KBTBD8 in cells, where hundreds of proteins compete for
access to CK2 (Bian et al., 2013). The CUL3KBTBD8-dependent binding and monoubiquitylation of
NOLC1, formation of TCOF1-NOLC1 complexes, and differentiation of hESCs into neural crest cells
required at least seven CK2 motifs. We note that the presence of all 10 CK2 motifs resulted in more
robust KBTBD8 recognition and neural crest specification, indicating that most, if not all, E3 binding
sites contribute to CUL3KBTBD8-substrate ubiquitylation and cell differentiation. We conclude that
CUL3KBTBD8 relies on multisite substrate phosphorylation for optimal target selection.
Figure 6 continued
conversion (NC1), and bound endogenous KBTBD8, TCOF1, or CK2 were detected by western blotting using specific antibodies. (C) Scheme of CK2-
mutants of NOLC1. CK2 motifs that remained functional are labeled with a red dot; the last two CK2 motifs of NOLC1 do not mediate KBTBD8-binding
in vitro, as shown above. (D) KBTBD8-recognition of NOLC1 depends on multiple CK2 motifs. The indicated NOLC1 variants were affinity-purified from
293 T cells and analyzed for binding to endogenous KBTBD8 or CK2b by western blotting using specific antibodies. Note that wild-type NOLC1, which
contains all 10 functional CK2 motifs is the most efficient KBTBD8-recruiter. (E) Multisite dependency of NOLC1 ubiquitylation in cells. Ubiquitylated
NOLC1 mutants were purified under denaturing conditions from 293 T cells that expressed HISubiquitin and, where indicated, KBTBD8HA. Ubiquitylation
of FLAGNOLC1 was analyzed by aFLAG-Western; note that NOLC1 mutants containing up to five CK2 motifs are ubiquitylated by an E3 ligase distinct
from KBTBD8 (i.e. ubiquitylation is observed in the absence of KBTBD8 expression in these cells). Ubiquitylation of endogenous PCNA was monitored
by western blotting using specific antibodies. (F) Multisite dependency of TCOF1-NOLC1 complex formation. FLAGNOLC1 variants with increasing
numbers of CK2 motifs were affinity-purified from 293 T cells that expressed KBTBD8 as indicated. Complex formation with endogenous TCOF1 was
monitored by western blotting using specific antibodies. In addition, overexpression of KBTBD8 allowed for KBTBD8 recognition already in the
presence of five CK2 motifs, consistent with multisite dependency providing an increase in affinity (i.e. that can in part be overcome by overexpression),
rather than creating a specific complex E3 recognition element.
DOI: https://doi.org/10.7554/eLife.35407.011
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Figure 7. Multisite dependency of CUL3KBTBD8 during neural crest specification. (A) Multiple CK2 motifs in NOLC1 are required for its role in neural
crest specification. Control or NOLC1-depleted H1 hESCs were generated by stable expression of shRNAs. Cells were then reconstituted with
doxycycline-inducible wildtype (WT) or CK-mutants of NOLC1 and subjected to neural conversion for 6 days. The outcome of cell differentiation was
Figure 7 continued on next page
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Our results are reminiscent of the yeast CDK inhibitor SIC1, whose recognition by the E3
ligase SCFCDC4 requires ~5–6 phosphorylation events (Csizmok et al., 2017; Nash et al., 2001;
Tang et al., 2007). In a mechanism referred to as allovalency, its multiple E3 binding sites allow
the intrinsically disordered SIC1 to rapidly rebind SCFCDC4 after a single motif dissociated. Simi-
lar to SIC1, TCOF1 and NOLC1 have multiple E3 binding motifs that are embedded in an acidic
domain of intrinsic disorder (IDRs). TCOF1 and NOLC1, however, differ from SIC1 in that they
contain a positively charged carboxy-terminal IDR with nuclear and nucleolar localization signals.
Biophysical work suggested that ampholytic IDRs, such as TCOF1 or NOLC1, adopt a compact
globular conformation that can undergo rapid structural fluctuations (Das and Pappu, 2013). We
therefore speculate that most CK2 motifs in TCOF1 and NOLC1 are buried in a collapsed con-
formation of the IDRs, while some CK2 motifs are frequently, yet stochastically, exposed on the
surface of the substrate. The exposed CK2 motifs are recognized by a conserved positively
charged loop in KBTBD8 and potentially a second substrate binding site whose existence was
implied by the behavior of the KBTBD8W579A variant. The compact conformation of its IDRs
might limit the propensity of unstructured TCOF1 and NOLC1 to aggregate, while its multiple
E3 recognition motifs ensure that ubiquitin-dependent signaling is still possible (Figure 8). We
propose that multisite dependency of an E3 ligase provides an elegant mechanism to control
the activity of intrinsically disordered proteins, which have now been linked to many important
cell behaviors (Shin and Brangwynne, 2017).
Implications for ubiquitin-dependent signaling
The mechanism for CUL3KBTBD8-substrate recognition implies that multiple residues in TCOF1 or
NOLC1 could serve as acceptor sites for monoubiquitylation. As mentioned before, we found that
TCOF1 is ubiquitylated in cells on several Lys residues, even though we have not observed multi-
monoubiquitylation (i.e. multiple Lys residues in the same substrate are modified with ubiquitin at
the same time). It is difficult to rationalize ubiquitylation events that are agnostic to a particular Lys
residue with binding of effector proteins that typically recognize both ubiquitin and a proximal sub-
strate motif (Husnjak and Dikic, 2012), and indeed, ubiquitin-binding domains have not yet been
identified in TCOF1, NOLC1, or their interaction partners. Rather than promoting a specific interac-
tion, we anticipate that the ubiquitin subunits attached to TCOF1 and NOLC1 function as steric
block or solubilizing domain to pry open the compact conformation of both substrates. This confor-
mational change could allow TCOF1 and NOLC1 to engage their partners during ribosome biogene-
sis and neural crest specification. Understanding this potential role of ubiquitylation in cellular
signaling will rely on reconstitution of the monoubiquitylation-dependent formation of TCOF1-
NOLC1 complexes, which is currently impossible due to difficulties in the purification of these large
and unstructured proteins. Why CUL3KBTBD8 stops after having transferred a single ubiquitin is also
an open question that will be an interesting basis for experiments aimed at elucidating mechanisms
of monoubiquitylation.
Multisite phosphorylation allows cells to integrate numerous environmental cues into a coherent
signaling response, or to introduce ultrasensitivity and threshold effects into signaling circuits (Guna-
wardena, 2005). In case of a distributive kinase, such as CK2, the probability of complete substrate
phosphorylation decreases the more sites have already been targeted by the enzyme (Serber and
Ferrell, 2007). This behavior is likely exacerbated by the large number of CK2 substrates in cells
that can act as sponges to titrate the kinase away from TCOF1 and NOLC1. Thus, while the low
Figure 7 continued
monitored by western blotting using specific antibodies against PAX6 (CNS precursor marker), SNAIL2 and SOX10 (neural crest markers), and GAPDH
(control). (B) Multiple CK2 motifs in NOLC1 are required for its role in neural crest specification. H1 hESCs expressing wild type or NOLC1CK variants
were generated and subjected to neural conversion as described above, and the outcome of differentiation was monitored using qRT-PCR of markers
of the CNS (FOXG1, SIX3, PAX6) or the neural crest (SOX10, SNAIL2, FOXD3). (C) Multiple CK2 motifs in NOLC1 are required for its role in neural crest
specification, as seen at single-cell resolution by fluorescence microscopy analysis. H1 hESCs expressing wild type or specific NOLC1CK mutants were
generated and subjected to neural conversion as described above, and neural crest differentiation was monitored by immunofluorescence microscopy
using anti-SOX10 antibodies. (D) Quantification of SOX10-positive cells in Figure 7C (n = 3, two biological and one technical replicate; error bars
denote s.e.m).
DOI: https://doi.org/10.7554/eLife.35407.012
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constitutive activity of CK2 in stem cells might lead to some TCOF1 or NOLC1-phosphorylation, only
the increase in CK2 activity observed during nervous system development should enable phosphory-
lation to the extent required for substrate recognition by CUL3KBTBD8. Based on these observations,
we propose that multisite dependency of CUL3KBTBD8 establishes a threshold concentration for CK2,
which needs to be surpassed for monoubiquitylation-dependent neural crest specification at specific
stages of embryogenesis.
Mutations in TCOF1 are the major cause of Treacher Collins Syndrome, a craniofacial disease that
is characterized by aberrant neural crest specification and survival (The Treacher Collins Syndrome
Colla, 1996; Wise et al., 1997). The mutations in TCOF1 map throughout the IDR and typically lead
to a truncated protein that has fewer phosphorylation sites and hence is less likely to engage in mul-
tisite phosphorylation and monoubiquitylation. These mutations also delete carboxy-terminal nuclear
and nucleolar localization sequences (Isaac et al., 2000), and thus, additionally disrupt targeting of
TCOF1 to the nucleolus. Treacher Collins Syndrome is further characterized by an environmental
component that strongly affects the phenotypic strength of identical TCOF1 mutations across
patients. It is possible that DNA damage or oxidative stress, which result in TCOF1 modification by
kinases other than CK2 (Ciccia et al., 2014; Larsen et al., 2014; Sakai et al., 2016), compete with
multisite phosphorylation by CK2. If this were to be the case, mutations that reduce the number of
available CK2 sites and environmental conditions that funnel TCOF1 into alternative pathways likely
Figure 8. Model of multisite-dependent substrate recognition by CUL3KBTBD8. CUL3KBTBD8-substrates TCOF1 and NOLC1 are first phosphorylated by
CK2 in conserved CK2 motifs (12 motifs in TCOF1; 10 motifs in NOLC1), which increases the negative charge of the central intrinsically disordered
region (IDR). Phosphorylation likely occurs on multiple Ser residues within a CK2 motif (see insert). While the phosphorylated substrate likely adopts a
compact conformation, CK2 motifs are stochastically exposed, allowing for their recognition by KBTBD8. We speculate that the resulting
monoubiquitylation of TCOF1 and NOLC1 opens up their conformations to allow for recognition of ribosome biogenesis factors, including RNA
polymerase I, the pseudouridylation machinery, and the SSU processome. As shown previously (Werner et al., 2015), the subsequent production of
new, and likely modified, ribosomes then triggers neural crest specification.
DOI: https://doi.org/10.7554/eLife.35407.013
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synergize to prevent monoubiquitylation-dependent neural crest specification. In these cases, our
data suggests that inhibition of phosphatases that oppose CK2 or approaches that activate CK2
kinase output could ameliorate phenotypes of TCOF1 mutation. Conversely, inhibition of CK2 might
provide therapeutic benefit against melanoma, a cancer driven by aberrant expression of KBTBD8
(Hayward et al., 2017). Our discovery of multisite phosphorylation as key to CUL3KBTBD8-substrate
recognition and neural crest specification could therefore be an important step towards developing
therapies against severe human pathologies.
Materials and methods
Plasmids and shRNAs
For transient expression in human cells, the following constructs were generated as previously
described (Werner et al., 2015): pCMV-3xFlag-TCOF1, pCMV-3xFlag-NOLC1, pCS2-3xHA-TCOF1,
pCS2-HA-NOLC1, pCDNA5-KBTBD8(WT, Y74A, F550A, W579A) 3xFlag, pCDNA5-KBTBD8-(WT,
Y74A)-HA, pCDNA5-KLHL12-3xFlag, pCS2-6xHis-ubiquitin. KBTBD85HK (HKH296-298AAA, KK300-
301AA) and monomeric KBTBD8L36D/L39D/M42D/N66K were generated by primer extension PCR using
nested primers. To generate NOLC1CK1 (NOLC1 mutant containing only one functional CK2 phos-
phorylation motif; all others were inactivated by mutation of two to three amino acids of the CK2
motif to Arg), the central repeat of NOLC1 was synthesized with the desired mutations as gBlock
gene fragment (IDT) and cloned with its wild type N- and C-terminus into pCMV-3xFlag by Gibson
assembly. To obtain NOLC1CK3, NOLC1CK5, NOLC1CK7, and NOLC1CK9, respective DNA fragments
were PCR amplified from NOLC1-WT or NOLC1-CK2-1 and assembled by Gibson cloning (Table 1).
KBTBD85HK and monomeric KBTBD8L36D/L39D/M42D/N66K were cloned into pFASTBacHTB with an
N-terminal His-tag for expression in SF9 cells using the Bac-to-Bac baculovirus system (Invitrogen) as
described for KBTBD8-WT, -F550A, and -W579A (Werner et al., 2015). TCOF1 and NOLC1 frag-
ments were cloned with an N-terminal His/FLAG-tag in pET28a (Table 2). Plasmids for bacterial
expression of CK2a (#27083) and CK2b (#27085) were purchased from Addgene.
For expression in hESCs, KBTBD85HK was cloned into pENTR1A-EF1a with a C-terminal FLAG-tag
and recombined into pLENTI-X1-Hygro as previously described for KBTBD8-WT (Werner et al.,
Table 1. Mutations introduced in different NOLC1-CK2 mutants.
NOLC1 CK2 mutant Amino acids mutated to R
CK1 CK2 motif 1: D86, S91
CK2 motif 2: S128, S133
CK2 motif 3: D168, D172, E176
CK2 motif 4: S227, S230
CK2 motif 5: S266, S271
CK2 motif 6: S322, S326, S332
CK2 motif 7: S362, S366, S370
CK2 motif 8: S425, S432
CK2 motif 9: S470, S47
CK3 CK2 motif 3: D168, D172, E176
CK2 motif 4: S227, S230
CK2 motif 5: S266, S271
CK2 motif 6: S322, S326, S332
CK2 motif 7: S362, S366, S370
CK2 motif 8: S425, S432
CK2 motif 9: S470, S477
CK5 CK2 motif 5: S266, S271
CK2 motif 6: S322, S326, S332
CK2 motif 7: S362, S366, S370
CK2 motif 8: S425, S432
CK2 motif 9: S470, S477
CK7 CK2 motif 7: S362, S366, S370
CK2 motif 8: S425, S432
CK2 motif 9: S470, S477
CK9 CK2 motif 9: S470, S477
DOI: https://doi.org/10.7554/eLife.35407.014
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2015). NOLC1-WT or CK2 mutant series was cloned with an N-terminal FLAG-tag into pENTR1A
and recombined into pINDUCER20 (Meerbrey et al., 2011). pLKO1-Puro Mission shRNA targeting
KBTBD8 (TRCN0000130280), CKb (TRCN0000000614), and NOLC1 (TRCN0000293796) were pur-
chased from SIGMA.
Table 2. TCOF1 and NOLC1 fragments cloned with N-terminal His6x-FLAG-tag in pET28a.
Fragment Amino acids Sequence
TCOF1-F1 72–108 QAKKTRVSDPI STSESSEEEEEAEAE TAKATPRLAST
TCOF1-F2 189–225 GMVSAGQ DSSSEDTSSSSDETDVE GKPSVKPAQVKA
TCOF1-F3 260–298 AKRAKKPEEESESSEEGSESEEE APAGTRSQVKASEKIL
TCOF1-F4 329–364 QTKAGKP EEDSESSSEESSDSEEE TPAAKALLQAKA
TCOF1-F5 399–431 AKAQAGKR EEDSQSSSEESDSEEE APAQAKPSG
TCOF1-F6 466–499 VQVGKQ EEDSRSSSEESDSDRE ALAAMNAAQVKP
TCOF1-F7 536–571 AQVGKW EEDSESSSEESSDSSDGE VPTAVAPAQEKS
TCOF1-F8 599–638 VKAEKPMDNSESSEESSDSADSEEAPAAMTAAQAKPALKI
TCOF1-F9 683–718 AGGTQRPA EDSSSSEESDSEEE KTGLAVTVGQAKSV
TCOF1-F10 754–783 VKAEKQ EDSESSEEESDSEE AAASPAQVKT
TCOF1-F11 864–893 P EEDSGSSEEESDSEEEAE TLAQVKPSGKT
TCOF1-F12 924–954 AQAGKQ DDSGSSSEESDSDGE APAAVTSAQV
NOLC1-F1 76–105 AKKAKKKA SSSDSEDSSEEEEE VQGPPAKK
NOLC1-F2 118–149 GKAAAKA SESSSSEESSDDDDEED QKKQPVQK
NOLC1-F4 207–242 APKIANGKAA SSSSSSSSSSSSDDSEEE KAAATPKK
NOLC1-F5 255–283 VKAATTPTRK SSSSEDSSSDEEEE QKKPM
NOLC1-F6 313–346 AVEKQQPV ESSEDSSDESDSSSEEE KKPPTKAVV
NOLC1-F7 350–384 TTKPPPAKKAA ESSSDSSDSDSSEDDE APSKPAGT
NOLC1-F8 415–448 QKLLTRKA DSSSSEEESSSSEEE KTKKMVATTKP
NOLC1-F9 460–494 AKQAPQGSR DSSSDSDSSSSEEEEE KTSKSAVKKK
NOLC1-F10 510–544 AKKGKA ESSNSSSSDDSSEEEEE KLKGKGSPRPQA
NOLC1-F11 552–586 ALTAQNGKAAKN SEEEEEE KKKAAVVVSKSGSLKK
NOLC1-F12 619–648 EKRASSPFRRVR EEEIEVDS RVADNSFDAK
NOLC1-F2 WT 196–212 DSSSEDTSSSSDETDVE
NOLC1-F2 S1A 196–212 DASSEDTSSSSDETDVE
NOLC1-F2 S3A 196–212 DAAAEDTSSSSDETDVE
NOLC1-F2 S7A 196–212 DAAAEDTAAAADETDVE
NOLC1-F2 S1R 196–212 DSRSEDTSSSSDETDVE
NOLC1-F2 S2R 196–212 DSRSEDTSSRSDETDVE
TCOF1* 190–364 Contains CK2 motif 2–3
NOLC1* 76–187 Contains CK2 motif 2–3
TCOF1-R1/2 72–225 Contains CK2 motif 1–2
TCOF1-R1/3 72–298 Contains CK2 motif 1–3
TCOF1-R1/4 72–364 Contains CK2 motif 1–4
TCOF1-R1/6 72–499 Contains CK2 motif 1–6
TCOF1-R1/8 72–638 Contains CK2 motif 1–8
TCOF1-R3/8 260–638 Contains CK2 motif 3–8
TCOF1-R5/8 399–638 Contains CK2 motif 5–8
TCOF1-R7/8 536–638 Contains CK2 motif 7–8
DOI: https://doi.org/10.7554/eLife.35407.015
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Antibodies
Mouse anti-KBTBD8 antibodies (1 mg/mL in IB) were described previously (Werner et al., 2015).
Mouse anti-Flag (F1804, clone M2, Sigma, 1:2000 in IB), rabbit anti-PAX6 (Biolegend, PRB-278B,
1:300 in IF), rabbit anti-CK2a (#2656S, Cell Signaling 1:500 in IB) rabbit anti-CK2b (A301-984,
Bethyl,1:500 in IB), rabbit anti-CK2 substrate (#8738S, Cell Signaling 1:500 in IB), mouse anti-PCNA
clone PC10 (sc56, Santa Cruz, 1:500 in IB), rabbit anti-GAPDH (#2118, clone 14C10, Cell Signaling,
1:10,000 in IB), rabbit anti-ARRB1/2 (#4674, clone D24H9, Cell Signaling, 1:1000 in IB), mouse anti-
PKN1 (610687, clone 49/PRK1, BD Bioscience, 1:1000 in IB), rabbit anti-PP1 (#2582, Cell Signaling,
1:100 in IB), rabbit anti-PP2A A (#2041, clone 81G5, Cell Signaling, 1:1000 in IB), rabbit anti-PP2A B
(#2290, clone 100C1, Cell Signaling, 1:1000 in IB), rabbit anti-PP2A C (#2259, clone 52F8, Cell Sig-
naling, 1:1000 in IB), rabbit anti-CUL3 (Bethyl, 1:1000 in IB), rabbit anti-NANOG (#3580, Cell Signal-
ing, 1:1000 in IB), goat anti-OCT4 (ac-8628, Santa Cruz, 1:1000 in IB), rabbit anti-SNAIL2 (#9585,
clone C19G7, Cell Signaling, 1:500 in IB), rabbit anti-TCOF1 (11003–1-AP, Proteintech, 1:250 in IB),
and rabbit anti-NOLC1 (11815–1 P, Proteintech, 1:1000 in IB) antibodies were commercially
purchased.
Proteins
KBTBD8 and KBTBD8 mutant variants (F550A, W579A, 5HK, Ddimer) were purified from SF9 cells 72
hr after transduction. In brief, lysates were prepared in 50 mM sodium phosphate, pH 8, 500 mM
NaCl, and 10 mM imidazole by incubation with 200 mg/ml lysozyme and sonication. Lysates were
cleared by centrifugation and incubated with Ni-NTA (QIAGEN) for 2 hr at 4˚C. Beads were washed
with lysis buffer containing 0.1% Triton followed by elution of proteins in 200 mM imidazole in 50
mM sodium phosphate, pH 8, 500 mM NaCl. TEV protease for His-tag removal was added and pro-
teins were dialyzed overnight into 50 mM Tris pH 8.0, 100 mM NaCl, 2 mM DTT, 10% glycerol. Pro-
teins were concentrated and purified by gel filtration using a Superdex 200 column and 20 mM
HEPES pH 7.4. 150 mM NaCl, 2 mM DTT. KBTBD8 fractions were concentrated, aliquoted, flash-fro-
zen in liquid nitrogen, and stored at  80˚C.
TCOF1 and NOLC1 fragments were purified from E.coli LOBSTR cells. Cell were grown in LB
medium to an OD600 of ~0.6 followed by addition of 0.5 mM IPTG to induce protein production at
37˚C for 3 hr. Cells were harvested and lysed in 15 mL of lysis buffer A (50 mM TRIS pH 8.0, 50 mM
NaCl, 1 mM PMSF, 1 mM EDTA, 3 U/mL Benzonase, 5 mg/mL Lysozyme) per 1.5 L of culture. After
incubation for 30 min at 4˚C, 10 mL of lysis buffer B (75 mM TRIS pH 8.0, 1425 mM NaCl, 1.5 mM
PMSF, 15 mM b-mercaptoethanol, 30 mM imidazole per 1.5 L culture were added followed by soni-
cation on ice. Lysates were cleared by centrifugation. His-tagged TCOF1 and NOLC1 fragments
were isolated using NI-NTA resin (Qiagen), washed with wash buffer (50 mM TRIS pH 8.0, 500 mM
NaCl, 1 mM PMSF, 5 mM b-mercaptoethanol, 20 mM imidazole), eluted in elution buffer (50 mM
TRIS pH 8.0, 300 mM NaCl, 1 mM PMSF, 5 mM b-mercaptoethanol, 250 mM imidazole), and trans-
ferred into storage buffer (50 mM TRIS pH 8.0, 300 mM NaCl, 1 mM PMSF, 5 mM b-mercaptoetha-
nol, 15% glycerol) by three cycles of concentration/dilution using Amicon Ultra centrifugal filter units
(EMD Millipore, MWCO 3 kDa). Longer TCOF1 fragments (TCOF1-R1/6 and TCOF1-R1/8) were fur-
ther purified by molecular sieving over a Superdex 200 column in 20 mM HEPES, pH 7.4, 150 mM
NaCl, 1 mM DTT, 10% glycerol, followed by concentration of protein-containing fractions. Concen-
trated proteins were aliquoted, flash-frozen in liquid nitrogen, and stored at  80˚C.
Nedd8-modified CUL3/RBX1, CK2a, CK2a/b, and E1/UBE2D3 were purified as previously
described (Jin et al., 2012; Meyer and Rape, 2014; Turowec et al., 2010). Initial CUL3/
RBX1 ~ Nedd8 purifications were a kind gift from Brenda Schulman.
Mammalian cell culture and transfection
Human embryonic kidney (HEK) 293 T cells were maintained in DMEM with 10% fetal bovine serum.
Plasmid transfections of HEK 293 T cells were with PEI or TransIT-293 Reagent (MIR207, Mirus)
according to the manufacturer’s instructions. For in vivo ubiquitylation assays, a plasmid ratio of 7.5:
2.5: five for His-ubiquitin: KBTBD8: TCOF1/NOLC1 was used. 293 T cells were routinely tested for
mycoplasma infections.
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hESC cell culture
Human embryonic stem (hES) H1 cells were obtained from the Wisconsin stem cell bank and main-
tained under feeder-free conditions on Matrigel-coated plates (#354277, BD Biosiences) in mTeSR 1,
(#05871/05852, StemCell Technologies Inc.). hES H1 cells were routinely passaged with collagenase
(#07909, StemCell Technologies Inc.). hESCs were routinely tested for mycoplasma infection.
Lentiviral production and infection
Lentiviruses were produced in 293 T cells by co-transfection of lentiviral constructs with packaging
plasmids (Addgene) for 48 hr. Viruses were collected and filtered through a 0.45 mm filter. For pIND-
CUER20 and pLENTI constructs, viruses were concentrated using LENTI-X concentrator (Takara) and
directly used for infection. For pLKO1 constructs, supernatant was aliquoted and stored at  80˚C.
HEK293T cells were transduced in polybrene (6 mg/ml) and selected with 1 mg/mL puromycin for 5
days. hES H1 cells were transduced as single-cell suspensions (prepared by treatment with accutase;
2.5  10e5 cells per well of a six-well plate) and in the presence of polybrene (6 mg/ml) and 10 mM
Y-27632 ROCK inhibitor for 90 min. In case of pINDUCER20 and pLENTI constructs, cells were cen-
trifuged during infection period at 30˚C and 1000 g. After infection, medium was changed to mTESR
containing 10 mM Y-27632 ROCK inhibitor. Selection of cells hES H1 cells was performed for 7 days
using appropriate antibiotics (pLKO1: 1 mg/mL Puromycin, pLENTI-Hygro: 200 mg/mL hygromycin,
pINDUCER20: 200 mg/mL G418).
Neural conversion of hESCs
Neural induction of hES H1 cells expressing different shRNA or protein constructs was performed
using STEMdiffTM Neural Induction Medium (#05831, StemCell Technologies Inc.) in combination
with a monolayer culture method according to the manufacturer’s technical bulletin (#28044) and as
previously described (Werner et al., 2015). In brief, single cell suspensions were prepared by treat-
ment of hES cells with accutase (1.25  106 cells were seeded per well of a six-well plate in STEMdiff
Neural Induction Medium supplemented with 10 mM Y-27632 ROCK inhibitor. Neural induction was
performed for indicated time periods with daily medium change. To determine the effect of CK2 or
PP1/PP2A inactivation on neural conversion, indicated concentrations of CX4945 or okadaic acid
were added throughout the differentiation experiment. For NOLC1 rescue experiments, to induce
expression of NOLC1 variants, 1 mg/mL doxycycline was added to indicated conditions for 12 hr
before the start and until the end of the differentiation experiment.
Immunoprecipitation
Small scale anti-FLAG and anti-HA immunoprecipitations (IPs) were performed from extracts of
HEK293T cells transiently expressing indicated constructs. Lysis was in two pellet volumes of 20 mM
HEPES pH 7.3, 50 mM NaCl 110 mM KOAc, 2 mM Mg(OAc)2, 5 mM EDTA, 5 mM EGTA, 0.2% NP-
40, and protease inhibitors (Roche) on ice. Lysates were sonicated, cleared by centrifugation, pas-
saged through a 0.45 mm membrane filter, and incubated with ANTI-FLAG-M2 agarose (Sigma) or
EZview Red Anti-HA affinity gel for 2 hr at 4˚C. After washing with lysis buffer, FLAG-tagged or HA-
tagged protein complexes were eluted with sample buffer and analyzed by SDS page and immuno-
blotting using indicated antibodies. For immunoprecipitation of FLAGNOLC1 from self-renewing and
differentiating hESCs (hESCs undergoing neural conversion for 1d), 1  15 cm dishes of cells
induced for flag-NOLC1 expression for 72 hr were used as starting material.
Mass spectrometry and compPASS analysis
For mass spectrometry analysis, FLAGNOLC1, and KBTBD8-5HKFLAG immunoprecipitates (originating
from 20  15 cm of transfected 293 T cells) were prepared and analyzed as previously described
(Werner et al., 2015). Samples were analyzed by the Vincent J. Coates Proteomics/Mass Spectrom-
etry Laboratory at UC Berkeley and compared with ~150 reference immunoprecipitations against dif-
ferent FLAG-tagged bait proteins using a Java script programmed according to the CompPASS
software suite (Huttlin et al., 2015). To identify regulators of CUL3KBTBD8 function, we compared
interactors found in IPs of its key targets FLAGTCOF1 (published in [Werner et al., 2015]) and FLAG-
NOLC1 (this study). For both FLAGTCOF1 and FLAGNOLC1, three independent IPs were compared as
replicates against the reference IPs. Thresholds for high confidence interaction partners (HCIPs)
Werner et al. eLife 2018;7:e35407. DOI: https://doi.org/10.7554/eLife.35407 21 of 27
Research article Biochemistry and Chemical Biology Cell Biology
were top 5% of interactors with highest Z-score and highest WD score. We then plotted relative
TSCs of HCIPs (normalized to 1000 TSC of bait) found in both FLAGTCOF1 and FLAGNOLC1 IPs. To
assess the impact of the mutation of the 5HK loop on the KBTBD8 interaction network, we analyzed
the abundance of KBTBD8 interactors (TSCs normalized to 1000 TSC of bait) found in IPs of different
KBTBD8 variants by cluster analysis. For this we used data sets from KBTBD8-WTFLAG, KBTBD8-
Y74AFLAG, KBTBD8-F550AFLAG, and KBTBD8-W579AFLAG IPs (Werner et al., 2015) and from
KBTBD8-5HKFLAG (this study).
For determination of TCOF1 ubiquitylation sites, His-ubiquitin, HATCOF1, and KBTBD8FLAG were
co-expressed in HEK 293 T cells and ubiquitylated TCOF1 conjugates were isolated by NiNTA pull
down. Fractions were separated by SDS-Page, stained with Coomassie, and gel pieces containing
TCOF1 ~Ub conjugates were excised (appropriate gel pieces were identified by simultaneous immu-
noblotting of a small NiNTA fraction run on a different gel). Proteins were subjected to in-gel diges-
tion using trypsin or gluC and analyzed by the Vincent J. Coates Proteomics/Mass Spectrometry
Laboratory at UC Berkeley. Protein identification was done with IntegratedProteomics Pipeline (IP2,
Integrated Proteomics Applications, Inc. San Diego, CA) using a false positive rate at the peptide
level of 0.25%. Individual spectra for ubiquitylated peptides were inspected to ensure that fragments
defined the ubiquitylation site.
Modeling of the KBTBD8 structure
A predicted 3D model of the KBTBD8 structure was obtained from the RaptorX web server. The
derived model was processed and analysed using PyMOL (The PyMOL Molecular Graphics System,
Version v1.3r1 Schro¨dinger, LLC.). The conservation analysis was done using the ConSurf server
(Landau et al., 2005).
In vitro phosphorylation assays
To ensure equal concentrations of purified TCOF1 and NOLC1 fragments for in vitro assays, protein
concentrations were determined using the Pierce BCA Protein Assay Kit (#23225, Thermo Scientific).
TCOF1 and NOLC1 fragments in concentrations ranging from 3.5 to 500 mM were phosphorylated
for 90 min at 30˚C using CK2 (#P6010, NEB, or self-purified as described above; cfinal = 0.1-2 mM)
and ATP (0.4 mM-2 mM) in PK buffer (#B6022S, NEB). For unphosphorylated controls, either ATP or
CK2 was substituted with H2O. Phosphorylation reactions were quenched by addition of EDTA to a
final concentration of 10 mM and subsequently used for binding assays.
In vitro binding assays
For KBTBD8 binding assays, ANTI-FLAG-M2 agarose (Sigma) beads were equilibrated in binding
buffer (20 mM HEPES pH 7.3, 110 mM KOAc, 2 mM Mg(OAc)2, 5 mM EGTA, 0.05% NP-40). Flag-
tagged TCOF1 and NOLC1 fragments from phosphorylation reactions were added into a 200 mL
reaction and incubated rotating for 1 hr at RT. Unbound protein fragments were rinsed three times
with 400 mL binding buffer. KBTBD8 and KBTBD8 mutant protein (5-15 mg/sample) were added to
the beads and incubated for 1 hr at RT on a rotator. After washing with binding buffer, bound pro-
tein was eluted with sample buffer and analyzed by SDS page and immunoblotting using indicated
antibodies.
For TCOF1 fragment binding assays, Protein G agarose (Sigma) beads were equilibrated in bind-
ing buffer and incubated with KBTBD8 or KBTBD8 mutant protein and mouse anti-KBTBD8 antibody
for 1 hr at RT. After washing out unbound protein with binding buffer, phosphorylated or unphos-
phorylated protein fragments were added to the reaction and incubated for 1 hr on a rotator. After
washing out unbound fragments with binding buffer, bound complexes were eluted with sample
buffer and analyzed by SDS page and immunoblotting using indicated antibodies.
Determination of the ultrasensitivity of the KBTBD8-TCOF1 interaction
Reactions of 4 mM TCOF1 fragment R1/8 in the presence or absence of tenfold excess of competitor
peptide (TCOF1-R1/2) were phosphorylated with 1 mM ATP using indicated CK2 concentrations in
PK buffer (#B6022S, NEB) at 30˚C for 1 hr. Phosphorylation reactions were stopped via addition of
EDTA to a final concentration of 10 mM.
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Protein G agarose (Sigma) beads were equilibrated in binding buffer and incubated with KBTBD8
(5 mg/sample) and mouse anti-KBTBD8 antibody for 1 hr at RT. After washing out unbound protein,
the phosphorylation reactions were added to immobilized KBTBD8 to a final concentration of 450
nM and incubated at RT for 1 hr. The binding reactions were washed, eluted in sample buffer and
analyzed by SDS page and immunoblotting using indicated antibodies. ImageJ was used for signal
quantification of two individual experiments. GraphPad was used for subsequent data processing
and analysis using the specific binding fit with Hill slope equation and data was plotted with the
standard error of the mean.
Fluorescence polarization assays
TAMRA-labeled TCOF1 peptide (5,6-[TAMRA]AGQDSSSEDTSSSSDETDVEGKP, bioSyntesis) and
competitor peptides were phosphorylated as described above. KD measurements were done at 100
nM TAMRA-TCOF1 peptide and indicated concentrations of KBTBD8 and KBTBD8 mutant proteins
in triplicates and duplicates, respectively. Competition assays were done in duplicates with 5 mM
KBTBD8 and 2.5 mM KBTBD8 Ddimer and indicated concentrations of TCOF1 competitors. Fluores-
cence polarization signal was measured using a BioTek Synergy H4 plate reader after 30 min incuba-
tion at RT in the dark. Data was processed and analyzed in GraphPad using the specific binding fit
with Hill slope equation and plotted with the standard error of the mean.
In vitro ubiquitylation assays
For in vitro ubiquitylation assays, 2 mM of His6x-FLAG-TCOF1-R1/2 and His6x-FLAG-TCOF1-R1/8
proteins were phosphorylated as described above and bound to anti-FLAG agarose in a 100 mL reac-
tion volume at RT for 1 hr. Beads were washed with binding buffer (20 mM HEPES pH 7.3, 50 mM
NaCl, 110 mM KOAc, 2 mM Mg(OAc)2, 1 mM EGTA, 0.1% NP-40) and incubated with 2 mM of
KBTBD8 in a 100 mL reaction volume at RT for 1 hr, followed by two washes of binding buffer. Liquid
was removed completely from beads and 20 mL ubiquitylation mix (0.5 mM Ube1, 1.0 mM UBE2D3,
40.0 mM ubiquitin, indicated concentrations of Cul3/Rbx1 ~ Nedd8, and 1 mM ATP in 20 mM TRIS
pH 7.5, 50 mM NaCl, 10 mM MgCl2) were added. Reactions were incubated at 30˚C for 1 hr and
then quenched by addition of 20 mL of 2X sample buffer. Eluates were analyzed by SDS-PAGE fol-
lowed by immunoblotting. Of note, immobilizing the substrates on FLAG-agarose and pre-binding
KBTBD8 was required for specific substrate modification.
In vivo ubiquitylation assays
For detection of TCOF1 and NOLC1 ubiquitylation, HEK293T cells were transfected with 6xHisUbiqui-
tin and KBTBD8FLAG. To determine the effect of CK2 inactivation, cells were stably transfected with
control or shRNAs targeting CK2b before plasmid transfection and treated with 20 mM CX4945 24
hr after plasmid transfection. To determine the effect on inactivation of PP1 and PP2A phosphatases,
cells were treated with 1 mM okadaic acid for 30 min prior to lysis. Cells were harvested 48 hr after
transfection, washed with PBS, lysed in 8M urea, 50 mM Tris-HCl pH 8.0, 10 mM imidazole and soni-
cated. 6xHisUbiquitin conjugates were purified by incubation and rotation with NiNTA agarose for 1
hr at room temperature. Beads were washed 2x with lysis buffer and 2x with lysis buffer at pH 6.3.
Ubiquitin conjugated were eluted in sample buffer and ubiquitylated proteins were detected by SDS
page followed by immunoblotting.
Quantitative real time PCR analysis
For qRT-PCR analysis, total RNA was extracted and purified from cells using the RNeasy Mini Kit
(Qiagen, catalogue no. 74104) and transcribed into cDNA using the RevertAid first strand cDNA syn-
thesis kit (#K1621, Thermo Scientific). Gene expression was quantified by Maxima SYBR Green/Rox
qPCR (#K0221, Thermo scientific) on a StepOnePlus Real-Time PCR System (Applied Biosystems).
Nonspecific signals caused by primer dimers were excluded by dissociation curve analysis and use of
non-template controls. To normalize for loaded cDNA, RPS6 was used as endogenous control.
Gene-specific primers for qRT–PCR were ordered pre-designed from Integrated DNA Technologies.
Primer sequences are summarized in Table 3.
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Immunofluorescence microscopy
For immunofluorescence analysis, hES H1 cells or hES H1 cells expressing different shRNA and/or
proteins and subjected to neural conversion for indicated time periods were seeded on Matrigel-
coated converslips using accutase, fixed with 3.7% formaldehyde for 10 min, permabilized with 0.1%
Triton for 20 min, and stained with anti-SOX10 antibodies and Hoechst. Random Images were taken
using a Zeiss LSM 710 confocal microscope with a 20x objective and processed using ImageJ.
SOX10-positive cells and total nuclei were counted (~150–200 cells per condition for each of the
three replicates) and average percentage of SOX10-positive cells was determined.
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Table 3. qPCR primers used in this study
qPCR primer Sequence
RPS6 right TGA TGT CCG CCA GTA TGT TG
RPS6 left TCT TGG TAC GCT GCT TCT TC
TFAP2 right ATT GAC CTA CAG TGC CCA GC
TFAP2 left ATG CTT TGG AAA TTG ACG GA
PAX6 right CAC ATG AAC AGT CAG CCA ATG
PAX6 left GGC CAG TAT TGA GAC ATA TCA GG
EDNRA right CAT GAC TTG TGA GAT GTT GAA CAG
EDNRA left CTG TTT TTG CCA CTT CTC GAC
FOXD3 right TTG ACG AAG CAG TCG TTG AG
FOXD3 left TCT GCG AGT TCA TCA GCA AC
SIX3 right CGA GGG GAG TGG ACA CTT
SIX3 left ATG CCG CTC GGT CCA AT
SNAI2 right TGA CCT GTC TGC AAA TGC TC
SNAI2 left CAG ACC CTG GTT GCT TCA A
SOX10 right CTT TCT TGT GCT GCA TAC GG
SOX10 left AGC TCA GCA AGA CGC TGG
FOXG1 right TGA ATG AAA TGG CAA AGC AG
FOXG1 left TGC AAT GTG GGG AGA ATA CA
DOI: https://doi.org/10.7554/eLife.35407.016
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